 clinic MR imag brain part phase II clinic trial patient presum intracrani neoplast diseas underw magnet reson MR intraven inject gadolinium carboxymethyl ododecan neutral nonion gadolinium chelat osmol equimolar concentr superior vitro stabil gadopentet dimeglumin safeti profil permit administr dose mmol/kg time dose gadopentet dimeglumin food drug administr limit clinic trial safe efficaci agent MR imag head chang patient monitor slight skin red inject site administr patient signific chang due administr agent laboratori evalu result gadopentet transient rise serum iron bilirubin level patient administr dose mmol/kg improv enhanc decreas efficaci high dose